中华病理学杂志
中華病理學雜誌
중화병이학잡지
Chinese Journal of Pathology
2014年
10期
695-698
,共4页
吴大鹏%夏永华%徐海斌%赵斌%梁秋冬%路坦%贾金领%董玉珍
吳大鵬%夏永華%徐海斌%趙斌%樑鞦鼕%路坦%賈金領%董玉珍
오대붕%하영화%서해빈%조빈%량추동%로탄%가금령%동옥진
骨肉瘤%垂体肿瘤转化基因1%细胞周期
骨肉瘤%垂體腫瘤轉化基因1%細胞週期
골육류%수체종류전화기인1%세포주기
Osteosarcoma%Pituitary tumor transforming gene 1%Cell cycle
目的 利用垂体肿瘤转化基因1(PTTG1) siRNA下调骨肉瘤细胞中PTTG1的表达,研究其表达下调对骨肉瘤细胞增殖、细胞周期和细胞侵袭能力的影响,并探讨其可能的分子机制.方法 采用Western blot检测3株骨肉瘤细胞(MG-63、SaOS-2和U2OS)和1株成骨细胞hFOB1.19中PTTG1蛋白的表达.用对照和PTTG1 siRNA转染骨肉瘤U2OS细胞,采用Western blot检测转染前后PTTG1蛋白的表达水平,分别利用细胞增殖与活性检测试剂盒、流式细胞术和Boyden小室检测PTTG1 siRNA对骨肉瘤U2OS细胞增殖、细胞周期和侵袭能力的影响,采用Western blot检测不同处理的U2OS细胞中Akt的活化状态及其下游靶基因的表达.结果 3株骨肉瘤细胞MG-63、SaOS-2和U2OS中PTTG1蛋白表达均高于成骨细胞hFOB1.19,其中U2OS中表达较高.PTTG1 siRNA能显著下调骨肉瘤U2OS细胞中PTTG1蛋白的表达,抑制U2OS细胞的增殖、改变细胞周期分布并降低侵袭能力.此外,PTTG1表达下调能抑制骨肉瘤细胞中p-Akt(S473和T308)、基质金属蛋白酶(MMP-2)和MMP-9的表达,提高p21和上皮性钙黏蛋白(E-cadherin)的表达.结论 PTTG1可能与骨肉瘤的发生发展关系密切,有望为骨肉瘤分子靶向治疗提供新策略.
目的 利用垂體腫瘤轉化基因1(PTTG1) siRNA下調骨肉瘤細胞中PTTG1的錶達,研究其錶達下調對骨肉瘤細胞增殖、細胞週期和細胞侵襲能力的影響,併探討其可能的分子機製.方法 採用Western blot檢測3株骨肉瘤細胞(MG-63、SaOS-2和U2OS)和1株成骨細胞hFOB1.19中PTTG1蛋白的錶達.用對照和PTTG1 siRNA轉染骨肉瘤U2OS細胞,採用Western blot檢測轉染前後PTTG1蛋白的錶達水平,分彆利用細胞增殖與活性檢測試劑盒、流式細胞術和Boyden小室檢測PTTG1 siRNA對骨肉瘤U2OS細胞增殖、細胞週期和侵襲能力的影響,採用Western blot檢測不同處理的U2OS細胞中Akt的活化狀態及其下遊靶基因的錶達.結果 3株骨肉瘤細胞MG-63、SaOS-2和U2OS中PTTG1蛋白錶達均高于成骨細胞hFOB1.19,其中U2OS中錶達較高.PTTG1 siRNA能顯著下調骨肉瘤U2OS細胞中PTTG1蛋白的錶達,抑製U2OS細胞的增殖、改變細胞週期分佈併降低侵襲能力.此外,PTTG1錶達下調能抑製骨肉瘤細胞中p-Akt(S473和T308)、基質金屬蛋白酶(MMP-2)和MMP-9的錶達,提高p21和上皮性鈣黏蛋白(E-cadherin)的錶達.結論 PTTG1可能與骨肉瘤的髮生髮展關繫密切,有望為骨肉瘤分子靶嚮治療提供新策略.
목적 이용수체종류전화기인1(PTTG1) siRNA하조골육류세포중PTTG1적표체,연구기표체하조대골육류세포증식、세포주기화세포침습능력적영향,병탐토기가능적분자궤제.방법 채용Western blot검측3주골육류세포(MG-63、SaOS-2화U2OS)화1주성골세포hFOB1.19중PTTG1단백적표체.용대조화PTTG1 siRNA전염골육류U2OS세포,채용Western blot검측전염전후PTTG1단백적표체수평,분별이용세포증식여활성검측시제합、류식세포술화Boyden소실검측PTTG1 siRNA대골육류U2OS세포증식、세포주기화침습능력적영향,채용Western blot검측불동처리적U2OS세포중Akt적활화상태급기하유파기인적표체.결과 3주골육류세포MG-63、SaOS-2화U2OS중PTTG1단백표체균고우성골세포hFOB1.19,기중U2OS중표체교고.PTTG1 siRNA능현저하조골육류U2OS세포중PTTG1단백적표체,억제U2OS세포적증식、개변세포주기분포병강저침습능력.차외,PTTG1표체하조능억제골육류세포중p-Akt(S473화T308)、기질금속단백매(MMP-2)화MMP-9적표체,제고p21화상피성개점단백(E-cadherin)적표체.결론 PTTG1가능여골육류적발생발전관계밀절,유망위골육류분자파향치료제공신책략.
Objective To downregulate the expression of pituitary tumor transforming gene 1 (PTTG1) in osteosarcoma (OS) cells by siRNA technology and to investigate related biological impact on cell proliferation,cell cycle and cell invasion of OS.Methods Three OS cell lines and osteoblast hFOB1.19 cell line were used in this study.Control siRNA and PTTG1 siRNA were employed to transfect OS U2OS cells,and PTTG1 protein level was detected by Western blot after the transfection.Effects of PTTG1 siRNA on cell proliferation,cell cycle and cell invasion were investigated by CCK-8,flow cytometry and Boyden chamber,respectively.Finally,activity of Akt and its downstream target gene expression were analyzed by Western blot in U2OS cells upon various treatments.Results Expression of PTTG1 protein in 3 OS cells (MG-63,SaOS-2 and U2OS) was significantly higher than that in osteoblast hFOB1.19,among which U2OS cells displayed the highest level.PTTG1 siRNA markedly downregulated the expression of PTTG1 protein in U2OS cells,leading to obvious inhibition of cell proliferation,altered cell cycle distribution and reduced ability of invasion of U2OS cells.Moreover,downregulation of PTTG1 reduced the expression of p-Akt (S473 and T308),MMP-2 and MMP-9 proteins,along with enhanced expression of p21 and E-cadherin proteins.Conclusions PTTG1 may be tightly linked to the development of OS and therefore may serve as a novel target for precision therapy of OS.